K2B Therapeutics is developing protein-drug/siRNA conjugates with the potential for tumor-agnostic treatment of cancer. Our team believes that K2B's conjugates will revolutionize cancer therapeutics to address significant unmet need. The foundational technology was developed at KIST (Korea Institut... Read more
This company has no org chart yet
This company has no teams yet
This company has no offices yet